English | Español
Patient Daily | Mar 22, 2026

Astellas ends partnership with CytomX despite positive early cancer drug data
Patient Daily | Mar 22, 2026

Rhythm’s Imcivree fails to meet main goal in late-stage obesity trial
Patient Daily | Mar 22, 2026

FDA issues third rejection for Aldeyra’s dry eye disease drug on March 17
Patient Daily | Mar 22, 2026

Federal judge blocks Kennedy’s vaccine policy overhaul, citing procedural failures
Patient Daily | Mar 22, 2026

FDA expands leucovorin use for rare disease amid scrutiny of regulatory standards
Patient Daily | Mar 22, 2026

Study links gut microbe molecules to coronary heart disease risk
Patient Daily | Mar 22, 2026

Binghamton University study links breakfast, exercise, and sleep to mental resilience
Patient Daily | Mar 22, 2026

Study reveals new dual role of ezrin in osteosarcoma

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'